Skip to content

Periodontitis and Cardiovascular Events or PAVE

Periodontal Intervention for Cardiac Events: A Pilot Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00066053
Enrollment
303
Registered
2003-08-05
Start date
2003-01-31
Completion date
2005-06-30
Last updated
2011-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease, Coronary Heart Disease, Myocardial Infarction, Cerebrovascular Accident

Keywords

Heart attacks, Stroke, Angina

Brief summary

The purpose of this study is to determine if treating periodontal infections (gum problems) will lead to fewer heart problems in patients at high risk for cardiovascular disease.

Detailed description

There is growing evidence of a strong association between infection and atherosclerosis as well as a specific link between periodontal infection (gum problems) and heart disease. Previous studies have established possible effective treatments of periodontal disease. These treatments may lead to fewer heart events in persons at high risk for cardiovascular disease. In contrast to previous heart disease studies, the primary treatment in this project is directed toward infectious agents at periodontal sites. This project is a pilot randomized clinical trial to test the feasibility of selecting and refining a periodontal infection treatment and examining the effect of that treatment on future heart events. It is a multi-center planning and pilot study involving five investigational centers at the University at Buffalo (lead and overall coordinating center), University of North Carolina, Boston University, Kaiser Permanente/Oregon Health Science University, University of Maryland, and a data coordinating center at the University of North Carolina. Central microbiology and cytokine laboratories and a biologic specimen bank are also included. A team of cardiologists, periodontists, epidemiologists, infectious disease specialists, biostatisticians, research nurses in periodontics and cardiology, and data managers has been assembled to accomplish the research with a careful, cost-effective approach. The ultimate goal is to develop a definitive randomized clinical trial that will include about 4,000 participants from approximately 15 centers across the United States

Interventions

PROCEDUREPeriodontal Treatment: SRP

Scaling and root planing. Subgingival tissue removal. Fluorides as needed. Oral hygiene instructions. Oral hygiene instructions.

PROCEDUREReferral

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
University at Buffalo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 75 Years
Healthy volunteers
No

Inclusion criteria

Eligibility: * Aged 75 years or less AND 50% or more blockage of at least one artery in the heart, * Heart problems in the last 3 years (including previous heart attack), * Previous heart bypass surgery, or previous heart angioplasty with or without a stent, AND at least 6 natural teeth present in the mouth AND evidence of mild to severe gum problems. Exclusion: Any of the following: * A major illness requiring hospitalization, * Renal dialysis, * Serum creatinine \> 3 mg/dl, * Organ transplant recipient requiring immunosuppression medication, * Surgery needed in the next 3 years, * Chemotherapy in the past 3 years, * Head and/or neck radiation at any time in the past, * Liver dysfunction, * Class IV congestive heart failure, * Drug or alcohol abuse, * Pacemaker or AICD/defibrillator.

Design outcomes

Primary

MeasureTime frame
Patient outcomes are hospitalized for myocardial infarction (MI), cardiac revascularization, fatal coronary heart disease, unstable angina, and/or hospitalized ischemic stroke.One year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026